未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial
Chew, Chun K.; Wang, Ruijie; Bavanandan, Sunita; Zainudin, Norliza; Zhao, Xiaoyuan; Ahmed, Sumeyya; Nair, Damenthi; Hou, Lihua; Yahya, Rosnawati; Ch'ng, Shereen S.; Pang, Lai H.; Abdul Aziz, Azrini; Huang, Haitao; Rajasuriar, Reena; Wu, Shipo; Zhang, Zhe; Wang, Xuewen; Chun, Geok Y.; Mohd Norzi, Aisyah; Cheah, Kit Y.; Lee, Yi L.; Wan Mohamad, Wan H.; Mohd Din, Mohamad R.; Wan Ahmad Kamil, Wan M. R.; Tan, Min H.; Xu, Xiaoyu; Wang, Lina; Yan, Meixu; Liu, Yusi; Chin, Voon K.; Teo, Jau S.; Lim, Teck O.; Zhu, Tao; Gou, Jinbo; Ng, Sharon S. M. 分享 收藏 Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18-49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical StudyWang, Yanxia; Shi, Gang; Wang, Xue; Xie, Zhiqiang; Gou, Jinbo; Huang, Lili; Huang, Haitao; You, Wangyang; Wang, Ruijie; Yang, Yongli; Wang, Feiyu; Zhu, Tao; Zhao, Dongyang 分享 收藏 Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trialXu, Jia-Wei; Wang, Bu-Sen; Gao, Ping; Huang, Hai-Tao; Wang, Fei-Yu; Qiu, Wei; Zhang, Yuan-Yuan; Xu, Yu; Gou, Jin-Bo; Yu, Lin-Ling; Liu, Xuan; Wang, Rui-Jie; Zhu, Tao; Hou, Li-Hua; Qing-Wang 分享 收藏 Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adultsJin, Zhili; Wu, Jingxuan; Wang, Ying; Huang, Tao; Zhao, Kexin; Liu, Jian; Wang, Haomeng; Zhu, Tao; Gou, Jinbo; Huang, Haitao; Wu, Xiaofang; Yin, Hang; Song, Jian; Li, Ran; Zhang, Jianxiong; Li, Lijun; Chen, Jingcheng; Li, Xiao; Zhang, Meijuan; Li, Jiangshuo; Hou, Mengyu; Song, Yuqin; Wang, Bingyan; Gao, Qiannan; Wu, Le; Kong, Yanhong; Dong, Ruihua 分享 收藏 Synthesis of cell penetrating peptide sterol coupler and its liposome study on S-mRNALi, Yuan; Ma, Wenlin; Su, Wen; Yan, Zhihong; Jia, Lin; Deng, Jie; Zhu, Ali; Xie, Yanbo; Li, Xinyi; Shao, Wanhui; Ma, Yuman; Che, Linze; Zhu, Tao; Wang, Haomeng; Li, Mingyuan; Yu, Peng 分享 收藏 Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccineLi, Mingyuan; Jia, Lin; Xie, Yanbo; Ma, Wenlin; Yan, Zhihong; Liu, Fufeng; Deng, Jie; Zhu, Ali; Siwei, Xue; Su, Wen; Liu, Xiaofeng; Li, Shiqin; Wang, Haomeng; Yu, Peng; Zhu, Tao 分享 收藏 Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipientsZhang, Zhe; Wu, Shipo; Liu, Yawei; Li, Kailiang; Fan, Pengfei; Song, Xiaohong; Wang, Yudong; Zhao, Zhenghao; Zhang, Xianwei; Shang, Jin; Zhang, Jinlong; Xu, Jinghan; Li, Yao; Li, Yaohui; Zhang, Jipeng; Fu, Kefan; Wang, Busen; Hao, Meng; Zhang, Guanying; Long, Pengwei; Qiu, Ziyu; Zhu, Tao; Liu, Shuling; Zhang, Yue; Shao, Fangze; Lv, Peng; Yang, Yilong; Zhao, Xiaofan; Sun, Yufa; Hou, Lihua; Chen, Wei 分享 收藏 Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3trialLi, Jing-Xin; Hou, Li-Hua; Gou, Jin-Bo; Yin, Zun-Dong; Wu, Shi-Po; Wang, Fu-Zhen; Zhang, Zhe; Peng, Zhi-Hang; Zhu, Tao; Shen, Hong-Bing; Chen, Wei; Zhu, Feng-Cai 分享 收藏 Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trialWu, Jun -Dong; Li, Jing-Xin; Liu, Jian; Wang, Hao-Meng; Zhou, Guang-Hui; Li, Jin; Wu, Dou; Chen, Xiang; Feng, Yan; Qi, Xiao-Yuan; Wang, Xue; Gou, Jin-Bo; Ma, Tie-Liang; Yang, Xiao-Yun; Xu, Li-Feng; Wan, Peng; Zhu, Tao; Wang, Zhong-Fang; Zhu, Feng-Cai 分享 收藏 Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trial用灭活SARS-CoV-2疫苗 (CoronaVac) 引发的60岁及以上健康成年人Ad5-nCOV异源免疫的免疫原性和安全性: 一项4期，随机，观察者盲，非劣效性试验Jin, Peng-Fei; Guo, Xi-Ling; Gou, Jin-Bo; Hou, Li-Hua; Song, Zhi-Zhou; Zhu, Tao; Pan, Hong-Xing; Zhu, Jia-Hong; Shi, Feng-Juan; Du, Pan; Huang, Hai-Tao; Liu, Jing-Xian; Zheng, Hui; Wang, Xue; Chen, Yin; Wan, Peng; Wu, Shi-Po; Wang, Xue-Wen; Xu, Xiao-Yu; Yan, Fang-Rong; Li, Jing-Xin; Chen, Wei; Zhu, Feng-Cai 分享 收藏 分享 收藏 Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical TrialsXia, Xin; Tan, Zhong-Ming; Wan, Peng; Zheng, Hao; Tang, Rong; Chen, Xiao-Qin; Guo, Xi-Ling; Zhu, Tao; Feng, Jia-Lu; Zhong, Jin; Li, Xiao-Long; Zhang, Zhen-Yu; Zhu, Feng-Cai; Li, Jing-Xin 分享 收藏 Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trialJin, Lairun; Tang, Rong; Wu, Shipo; Guo, Xiling; Huang, Haitao; Hou, Lihua; Chen, Xiaoqin; Zhu, Tao; Gou, Jinbo; Zhong, Jin; Pan, Hongxing; Cui, Lunbiao; Chen, Yin; Xia, Xin; Feng, Jialu; Wang, Xue; Zhao, Qi; Xu, XiaoYu; Li, Zhuopei; Zhang, Xiaoyin; Chen, Wei; Li, Jingxin; Zhu, Fengcai 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
OAAI